BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28703366)

  • 21. [Triptolide induces apoptosis of human acute T lymphocytic leukemia Jurkat cells via inhibiting transcription of human endogenous retrovirus HERV-K Np9 gene].
    Chen J; Zheng W; Jiang X; Lu X; Xu R
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):702-6. PubMed ID: 26018266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia.
    Pereira JK; Machado-Neto JA; Lopes MR; Morini BC; Traina F; Costa FF; Saad ST; Favaro P
    Eur J Cancer; 2015 Sep; 51(14):2076-85. PubMed ID: 26238016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
    Canté-Barrett K; Spijkers-Hagelstein JA; Buijs-Gladdines JG; Uitdehaag JC; Smits WK; van der Zwet J; Buijsman RC; Zaman GJ; Pieters R; Meijerink JP
    Leukemia; 2016 Sep; 30(9):1832-43. PubMed ID: 27174491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
    Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
    Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-leukemia effect of oridonin on T-cell acute lymphoblastic leukemia].
    Guo Y; Shan QQ; Gong YP; Lin J; Yang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):903-7. PubMed ID: 25571712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line.
    Tüfekçi Ö; Yandım MK; Ören H; İrken G; Baran Y
    Leuk Res; 2015 Mar; 39(3):342-7. PubMed ID: 25557384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
    Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
    Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells.
    Zheng LC; Wang XQ; Lu K; Deng XL; Zhang CW; Luo H; Xu XD; Chen XM; Yan L; Wang YQ; Shi SL
    Oncotarget; 2017 Jun; 8(25):41348-41363. PubMed ID: 28489586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
    Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
    Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury.
    Liang KW; Ting CT; Yin SC; Chen YT; Lin SJ; Liao JK; Hsu SL
    Biochem Pharmacol; 2006 Mar; 71(6):806-17. PubMed ID: 16448624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.
    Iacovelli S; Ricciardi MR; Allegretti M; Mirabilii S; Licchetta R; Bergamo P; Rinaldo C; Zeuner A; Foà R; Milella M; McCubrey JA; Martelli AM; Tafuri A
    Oncotarget; 2015 Oct; 6(31):32089-103. PubMed ID: 26392332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of rMnSOD on survival signaling in pediatric high risk T-cell acute lymphoblastic leukaemia.
    Pica A; Di Santi A; D'angelo V; Iannotta A; Ramaglia M; Di Martino M; Pollio ML; Schiattarella A; Borrelli A; Mancini A; Indolfi P; Casale F
    J Cell Physiol; 2015 May; 230(5):1086-93. PubMed ID: 25294747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.
    Tae N; Lee S; Kim O; Park J; Na S; Lee JH
    Oncotarget; 2017 Jun; 8(24):38886-38901. PubMed ID: 28418925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Statins Regulate the Proliferation and Apoptosis of T-ALL Cells through the Inhibition of Akt Pathway].
    Wang JJ; Tian Y; Xu KL; Fu RX; Niu MS; Zhao K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):359-367. PubMed ID: 29665899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells.
    Jung JI; Park KY; Kim SA; Kim J
    Biomed Pharmacother; 2018 Feb; 98():357-363. PubMed ID: 29275177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors.
    Batista A; Barata JT; Raderschall E; Sallan SE; Carlesso N; Nadler LM; Cardoso AA
    Exp Hematol; 2011 Apr; 39(4):457-472.e3. PubMed ID: 21277936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling.
    Liu X; Liu S; Chen J; He L; Meng X; Liu S
    Ann Hematol; 2016 Oct; 95(11):1787-93. PubMed ID: 27506924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sam68 affects cell proliferation and apoptosis of human adult T-acute lymphoblastic leukemia cells via AKT/mTOR signal pathway.
    Wang Q; Li Y; Cheng J; Chen L; Xu H; Li Q; Pang T
    Leuk Res; 2016 Jul; 46():1-9. PubMed ID: 27107742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A taspine derivative supresses Caco-2 cell growth by competitively targeting EphrinB2 and regulating its pathway.
    Dai B; Wang W; Ma Y; Liu R; Zhang Y
    Oncol Rep; 2016 Sep; 36(3):1526-34. PubMed ID: 27460008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.